Attached files

file filename
EX-23 - EXHIBIT 23 - ANGIODYNAMICS INCex23angio2015consent531161.htm
10-K - 10-K - ANGIODYNAMICS INCango-053116x10k.htm
EX-32.1 - EXHIBIT 32.1 - ANGIODYNAMICS INCex3215311610-k.htm
EX-31.2 - EXHIBIT 31.2 - ANGIODYNAMICS INCex3125311610-k.htm
EX-31.1 - EXHIBIT 31.1 - ANGIODYNAMICS INCex3115311610-k.htm
EX-21 - EXHIBIT 21 - ANGIODYNAMICS INCex2153116.htm
EX-10.4.3 - EXHIBIT 10.4.3 - ANGIODYNAMICS INCex104353116.htm
EX-10.1.5 - EXHIBIT 10.1.5 - ANGIODYNAMICS INCex101553116.htm
EX-3.1.2 - EXHIBIT 3.1.2 - ANGIODYNAMICS INCex31253116.htm


Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,
UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Peter Kish, Interim Chief Financial Officer of ANGIODYNAMICS, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:

1.
the annual report on Form 10-K of the Company for the fiscal year ended May 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 1, 2016

/s/ Peter Kish
Peter Kish,
Interim Chief Financial Officer